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Abstract: The Obesity pandemic will afflict future generations without successful prevention, 
intervention and management. Attention to reducing obesity before, during and after pregnancy 
is essential for mothers and their offspring. Preconception weight loss is difficult given that 
many pregnancies are unplanned. Interventions aimed at limiting gestational weight gain have 
produced minimal maternal and infant outcomes. Therefore, increased research to develop 
evidence-based clinical practice is needed to adequately care for obese pregnant women especially 
during antenatal care. This review evaluates the current evidence of obesity interventions during 
pregnancy various including weight loss for safety and efficacy. Recommendations are provided 
with the end goal being a healthy pregnancy, optimal condition for breastfeeding and prevent 
the progression of obesity in future generations. 
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1. A Rising Pregnancy Health Problem 
Pregnancy and infant health are commonly used to define a nation’s health and future. It also represents 
the quality and effectiveness of its health care and public health systems. For the past 20 years the rising 
obesity pandemic has received a great deal of press, policy and research but continues to elude successful 
remedy to date. Among women of childbearing age, obesity is paramount because of its association with 
multiple adverse health outcomes for both mother and fetus and even future generations [1]. When compared 
with other age groups, U.S. women aged 35 to 44 years have experienced the greatest increase in obesity 
prevalence in the past 45 years [2] and 45% of women begin pregnancy overweight or obese, up from 
24% in 1983 [3]. Gestational weight gain continues to exceed the 2009 Institute of Medicine (IOM) 
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guidelines, with 43% of pregnant women gaining more than is recommended [3]. However, considering 
that 22% of all global pregnancies are unplanned, current guidelines are not addressing the growing problem 
of being obese and becoming pregnant [4]. The total number of women who become pregnant in any given 
year is unknown, but approximately four million births occur in the United States annually and, currently, 
60% of women of childbearing age are either overweight or obese (Table 1) [3]. 
Table 1. The international classification of adult underweight, overweight and obesity according 
to Body Mass Index (BMI) adapted from the World Health Organization (WHO) [5]. 
Classification Principal Cut-off Points 
Underweight BMI < 18.5 kg/m2 
Normal BMI 18.5–24.99 kg/m2 
Overweight/pre-obese BMI 25–29.99 kg/m2 
Obese class 1 BMI 30–34.99 kg/m2 
Obese class 2 BMI 35–39.99 kg/m2 
Obese class 3 BMI ≥ 40 kg/m2 
There are multiple maternal complications of obesity during and after pregnancy with or without 
excess gestational weight gain including high blood pressure, preeclampsia, gestational diabetes, and 
cesarean delivery to name a few [5–23]. Obese pregnant women are at a higher risk of problems related 
to cesarean delivery—including complications with anesthesia, excessive blood loss, blood clots, and 
infection. Offspring are at increased risk for miscarriage, stillbirth, premature birth, or having a baby 
with a birth defect. 
In a recent cross-sectional survey of health behaviors, including obesity risk knowledge, weight 
misperception, and diet and health-related attitudes among women (aged 16 to 40 years) intending to become 
pregnant, 51% had low obesity risk knowledge and 31% misperceived their body weight [24]. Additionally, 
76% of these women felt confused about what constitutes a healthy diet, even though 47% believed that their 
current diet was healthy and saw no reason to change their current eating patterns. Weight misperception did 
not differ between the two groups, however, the overweight women intending to become pregnant were more 
likely to misperceive their weight than obese women intending to become pregnant (71% vs. 10%; p < 0.001). 
2. Objective 
The American College of Obstetrics and Gynecology’s (ACOG), National Institute of Health and 
Clinical Excellence (NICE) in the United Kingdom, Centers for Diseases Control, and the Academy of 
Nutrition and Dietetics’ recommendations suggest weight loss during preconception and/or limited 
gestational weight gain (GWG) [1,25–27]. The primary purpose of this paper is to examine recent data 
to date on hypocaloric feeding interventions to reduce maternal and neonatal complications and adverse 
outcomes of pregnant obese women and their fetus. 
2.1. What History Tells Us: Recent Systematic Reviews and Meta-Analyses 
A 2013 Cochrane Review, Antenatal Interventions for Reducing Weight in Obese Women for Improving 
Pregnancy Outcome, found no randomized controlled trials and recommended that further research is 
needed to evaluate the safety of interventions for weight loss when a woman is obese and becomes 
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pregnant [28]. Types of outcome measures examined included the following primary outcomes of serious 
maternal morbidity (admission to high dependency care) and/or death; neonatal admission to neonatal 
intensive care; and perinatal death (including still birth). Secondary maternal outcomes included gestational 
diabetes; fetal distress in pregnancy or labor; post-partum hemorrhage; caesarean birth; infection (including 
wound, urinary tract, perineum, chest and breast); and weight (loss/gain/no change) [28]. Neonatal outcomes 
comprised of birth weight < 2500 g and < 10th percentile for gestational age and gender; birth  
weight > 4000 g or > 90th percentile for gestational age and gender; preterm birth (birth < 37 completed 
weeks of pregnancy); Apgar scores < 7 at 5 min; and hypoglycemia, as deﬁned by researchers. Long-term 
outcomes were identified as maternal weight postpartum and childhood weight [28]. 
Subsequently, a systematic review by The Cochrane Collaboration, titled “Diet or exercise, or both, 
for preventing excessive weight gain in pregnancy” was aimed to determine whether diet or exercise 
measures, or both, could prevent excessive gestational weight gain (GWG), and if they were safe. The 
authors systematically analyzed 49 high quality RCTs out of a total of 65 RCTs comprising 11,444 women 
treated with diet or exercise, or both, or standard care [28]. Collectively, the interventions reduced the 
risk of excessive GWG on average by 20% overall (average risk ratio (RR) 0.80, 95% conﬁdence interval 
(CI) 0.73 to 0.87). Excessive GWG is WG above the 2009 IOM pregnancy weight gain guidelines [2]. 
Additionally, women receiving diet or exercise, or both interventions were more likely to experience low 
GWG than those in control groups (average RR 1.14, 95% CI 1.02 to 1.27); maternal hypertension (not 
a pre-speciﬁed outcome) was reduced in the intervention group compared with the control group overall 
(average RR 0.70, 95% CI 0.51 to 0.96) and a 13% (−1% to 25%) reduction for combined diet and 
exercise counselling interventions. However, no differences were found between intervention and control 
groups with regard to pre-eclampsia (RR 0.95, 95% CI 0.77 to 1.16); cesarean delivery overall (RR 0.95, 
95% CI 0.88 to 1.03); preterm birth overall (average RR 0.91, 95% CI 0.68 to 1.22); no clear difference 
between intervention and control groups with regard to infant macrosomia (average RR 0.93, 95% CI 0.86 
to 1.02); and no differences in the risk of poor neonatal outcomes including shoulder dystocia, neonatal 
hypoglycemia, hyperbilirubinemia, or birth trauma (all moderate-quality evidence) between intervention and 
control groups; however, infants of high-risk women had a reduced risk of respiratory distress syndrome if 
their mothers were in the intervention group (RR 0.47, 95% CI 0.26 to 0.85) [29]. 
Thangaratinam and colleagues in a systematic review and meta-analysis evaluated 44 RCTs (7278 
women) consisting of three categories of interventions: diet, physical activity, and a mixed method [30]. 
Results showed a 1.42 kg reduction (95% confidence interval 0.95 to 1.89 kg) in gestational weight gain 
with any intervention compared to control. When combining all interventions, there were no significant 
differences in birth weight (mean difference −50 g, −100 to 0 g) and the incidence of large for gestational 
age (relative risk 0.85, 0.66 to 1.09) or small for gestational age (relative risk 1.00, 0.78 to 1.28) babies 
between the groups, though by itself physical activity was associated with reduced birth weight (mean 
difference −60 g, −120 to −10 g). Interventions were associated with a reduced the risk of preeclampsia 
(relative risk 0.74, 0.60 to 0.92) and shoulder dystocia (relative risk 0.39, 0.22 to 0.70) [30]. 
Another systematic review and meta-analysis on restriction of gestational weight gain conducted by 
Quinlivan and colleagues found four RCTs comprised of 537 women that met the inclusion/exclusion 
criteria [31]. The intervention programs were effective in reducing the total gestational weight gain by 
6.5 kg. In spite of this, antenatal dietary interventions did not alter newborn birth weight (z = 0.18, p = 0.859). 
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More recently, a pilot RCT comprised of a multifaceted lifestyle (diet and exercise) treatment in obese 
pregnant women (the UPBEAT trial) found that baseline energy intake decreased from 1734 kcal/d to 
1612 kcal/d (a 7% decrease over seven months) [31]. Treatment dietary advice comprised of increasing low 
glycemic index (GI) carbohydrates, replacing sugar sweetened beverages with low GI replacements and 
replacing foods high in low saturated fat with polyunsaturated and monounsaturated fat alternatives. Physical 
activity advice encourage walking at a moderate intensity. Limiting energy intake was not recommended. 
Outcome data collected but not reported included diagnosis of GDM and gestational weight gain. 
Unfortunately, neither ketonuria nor ketonemia was measured. 
2.2. Non-Randomized Controlled Trials 
Little data exists on the effects of weight loss on fetal growth [32]. Other investigations and authors 
suggest rates of preeclampsia, caesarean delivery, and other adverse outcomes are reduced when weight gain 
is limited to seven kilograms [33,34]. Lower GWG and no GWG has been shown to not be harmful, but 
what about actual weight loss during pregnancy? Weight gain restriction during pregnancy is safe for 
both the mother and neonate [35,36]. When assessing weight gain restriction studies, it is difficult to 
determine the level of energy/macronutrient/micronutrient restriction used and whether metabolic monitoring 
was applied through adverse event reporting. 
A retrospective cohort of study of 1344 women with GDM evaluated the association of obesity with 
pregnancy outcomes in women via a medical record review [37]. Findings included higher mean fasting 
and postprandial glucose levels despite medication in the overweight and obese women. Obesity was 
associated with macrosomia (adjusted odds ratio [OR] 2.03, 95% confidence interval [CI] 1.07–3.89,  
p = 0.03), preterm birth (adjusted OR 2.21, 95% CI 1.02–4.78, p = 0.04), and hypertensive disorders of 
pregnancy (adjusted OR 2.19, 95% CI 1.38–3.49, p = 0.001). Obese women with fasting blood sugars 
greater than 88.7 mg/dL and postprandial blood sugars greater than 123.8 mg/dL. Increased blood pressure 
problems were significantly increased in obese women when gestational weight gain was >0.6 lb. per week 
(29.4% compared with 15.2%, p < 0.001) as compared to obese women with less weight gain [37]. 
Emerging evidence suggests that weight loss in pregnancy for obese women may have substantial 
benefits for both the mother and infant. In 2009, Oken and colleagues reviewed 2011 mother-child pairs 
against five adverse outcomes related to gestational weight gain: preterm birth, small-for-gestational-age 
infant, large-for-gestational-age infant, substantial maternal postpartum weight retention, and child obesity 
at age of three years. The results indicated that the lowest predicted prevalence of all five adverse outcomes 
occurred with a weight loss of 0.19 kg/week for obese women, which equates to a total loss of 7.6 kg 
for obese women over all of the pregnancy [30,38]. 
2.3. Metabolism during Pregnancy Compounded by Obesity 
Adipose tissue works as an endocrine organ and it is the metabolic function of adipose tissue that causes 
much of the pathology associated with obesity [39]. It stores and secretes preformed steroid hormones, 
converts precursors to biologically active hormones, and converts active hormones to inactive metabolites. 
Adipose tissue secretes enzymes needed for steroid hormone biosynthesis and metabolism, such as estrone, 
which is converted to estradiol in peripheral adipose tissue. Adipose tissue expresses 11--hydroxysteroid 
dehydrogenase type 1 (11--HSD1), which converts cortisone to cortisol, as well as 5--reductase, which 
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converts cortisol to 5--tetrahydrocortisol. Thus, adipose tissue regulates the local concentration of 
glucocorticoids and contributes to their metabolic clearance and secretes a large number of bioactive 
peptides and cytokines, (adipokines) (Table 2). The metabolic consequences of obesity are similar to the 
endocrine dysfunction seen in hyperplasia of any endocrine organ. 
Table 2. Enzymes and hormones produced by adipose tissue [39]. 
Enzyme/Hormone Function Changes Associated with Obesity 
Aromatase Converts androgens to estrogens 
No change with obesity, but  
increased fat mass results in  
greater total conversion 
17--hydroxysteroid 
hydrogenase 
Converts estrone to estradiol and 
androstendione to testosterone 
No change 
5--reductase Inactivates cortisol No change 
11--hydroxysteroid 
dehydrogenase type 1 
Converts cortisone to cortisol Activity is increased in obese women 
Leptin 
Affects food intake, timing of puberty, 
bone development, and immune function 
Circulating leptin levels are increased in 
obese women 
Tumor necrosis  
factor (TNF) 
Represses genes involved in the uptake 
and storage of nonesterfied fatty acids 
and glucose 
Expression of TNF is increased in the 
adipose tissue of obese women 
Adiponectin Enhances insulin action 
Circulating levels of adiponectin are 
decreased in obese women 
Carbohydrate (CHO) metabolism in pregnancy is characterized by mild fasting hypoglycemia,  
post-prandial hyperglycemia and hyperinsulinemia. In pregnant women, after CHO ingestion, there is 
prolonged hyperglycemia and hyperinsulinemia, as well as increased suppression of glucagon secretion [40]. 
This response is related to the induced state of peripheral insulin resistance (IR), which is even more 
pronounced in obese pregnant women and gestational diabetes [41]. The purpose of IR is thought to 
maintain a postprandial supply of glucose to the fetus as the fetus is estimated to utilize 20–25 g of glucose 
a day in late pregnancy [42]. 
Decreased insulin sensitivity during pregnancy is also related to lipid metabolism [43]. Increased 
concentrations of free fatty acids are related to decreased insulin ability to suppress lipolysis in late 
pregnancy. Freinkel used the term “accelerated starvation in pregnancy” to describe the increased risk 
of ketosis in pregnant women [44]. Lipid metabolism in obese women and in lean women experience 
the predominance of lipogenesis in the first trimester of pregnancy, and lipolysis in the third trimester. 
In obese women, lipogenesis occurs only in the pre-pregnancy period, whereas lipolysis predominates 
in all trimesters of pregnancy [45]. These data confirm insulin’s inability to suppress lipolysis in all 
women as pregnancy advances, and further confirm the evidence of increased IR in obese women, as 
compared to women with normal weight in earlier stages of pregnancy [43]. Obese pregnant women 
exhibit a more pronounced hyperlipidemia and the adipocytes and adipose stromal cells are a rich source of 
cytokines and inflammatory mediators, which can either increase IR (TNF-α), or reduce it (adiponectin). 
Contrary to expectations, there is no increase in measured protein synthesis in the first trimester, there 
is a 15% increase in the second trimester and a 25% increase in the third trimester [46]. The concentration 
of amino acids is higher in the fetus than the mother [47,48] and during pregnancy, most amino acids are 
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used for protein synthesis, with a decrease in their oxidation by approximately 10% [49]. Presently, the effects 
of obesity on amino acid metabolism are unknown. Because hyperinsulinemia decreases protein synthesis in 
non-pregnant obese women, there may be a possibility of impaired anabolic response to pregnancy and a 
mechanism limiting fetal growth. 
3. Weight Loss during Pregnancy 
History provides observations and studies of extreme states of weight loss and dieting during pregnancy 
in comorbidities such as hyperemesis gravidarum and malnutrition, starvation and the Dutch Famine 
and the hormonal effects of fasting during pregnancy. Although this data does not specifically address 
additional exposure to the state of obesity, these three conditions assess safety and maternal and fetal 
outcomes of nutritional deprivation during pregnancy. 
In starvation, suppression of the sympathetic nervous system likely contributes to a decrease in 
metabolic rate with energy restriction and together the stimulation of the adreno-medullary system 
allows for substrate mobilization with a minimal increase in energy expenditure [49]. In addition, 
starvation drastically reduces the amount of amino acids in the amniotic fluid [50]. However, it is still unclear 
when and how much deprivation is needed to inﬂuence pregnancy outcome positively and negatively. 
3.1. The Dutch Famine 
The Dutch famine in 1944–1945 exemplifies the effect of timing of poor nutrition on low birth weight [51]. 
Third trimester exposure accounted for the whole of the famine effects on birth weight whereas ﬁrst 
trimester exposure affected the length of gestation. Of particular note, the ﬁrst trimester pregnant woman 
is considered to be more vulnerable to stress and during the famine the stress of war may have been the 
stressor affecting gestational length but not birth weight. 
Offspring whose mothers had been exposed to famine in the second or third trimester had reduced 
glucose tolerance, shown by increased two-hour plasma glucose concentrations [52]. Those individuals 
who had smaller birth weights had increased two-hour plasma glucose concentrations. Children exposed to 
famine during the first trimester had a more atherogenic lipid proﬁle [53], somewhat higher ﬁbrinogen 
concentrations and reduced plasma concentrations of factor VII [54], a higher BMI [55] and they 
appeared to have a higher risk of CHD [51,56]. Offspring whose mothers consumed little protein relative to 
carbohydrate during the third trimester of pregnancy had higher blood pressures at adult age [57]. The 
implication is that blood pressure may be linked to a disruption in the balance of macronutrients in the 
maternal diet during late gestation rather than to absolute amounts of nutrients. 
Recognized infant outcomes of low birth weight, still birth and congenital anomalies from associated 
intrauterine exposure to famine have been associated with adult diabetes, obesity cardiovascular disease 
schizophrenia, cognitive aging, hypomethylation of IGF2 and INSIGF hypermethylation of ABCA1, 
GNASAS, IL10, LEP, and MEG3 stochastic methylation changes of several metastable epialleles [58,59]. 
Much of these long-term effects are from observations from the Dutch Hunger Winter Study and the 
discovery of the significance of timing in the fetal programming of adult disease. Those who were exposed 
to the famine only during late gestation were born small and continued to be small throughout their lives, 
with lower rates of obesity as adults than in those born before and after the famine [60]. Those offspring 
exposed during early gestation experienced elevated rates of obesity, altered lipid proﬁles, and cardiovascular 
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disease. Additionally, those exposed in mid-pregnancy demonstrated reduced renal function [61,62]. 
Those exposed to famine during early gestation later showed a signiﬁcant impairment in a test of selective 
attention at age 56–59 years [63]. These observations represented first critical windows of development 
preceding the developmental origins of health disease hypothesis [63]. Moderate nutritional deficiency 
experienced by the pregnant women of the Dutch Famine was considered to be a mean daily ration of 1000 
to 1500 calories per day with estimated intakes of 37 to 42 g of protein, 212 to 247 g CHO and 24 to 41 g 
of fat [55]. Severe nutritional deficiency exposure was judged to be a mean daily ration of <1000 calories 
per day, 14 to 22 g of protein, 114 to 144 g of CHO and 12 to 28 g of fat (Table 3) [55]. At the beginning 
of the famine, wartime maternal weights were low in comparison with the immediate postwar norm [55]. 
Maternal weight quickly dropped following a 39.4% reduction in food rations. From September 1944 
through April 1945, daily food rations changed from a high of 1924 calories to a low of 836 calories 
(Table 2) [55]. The average decline from the pre-famine level in the most affected cohort was 2.6 kg, or 
4.3%, and the rise with recovery was 5.9 kg, or 10.5% [55]. 
Table 3. The Dutch Famine daily food rations by week and pregnancy trimester periods July 
1944 to July 1945. 
Time Period Calories Protein Carbohydrate Fat 
September 1944 1924 (64%) 61 (73%) 295 (68%) 50 (42%) 
February 1945 836 (28%) 35 (42%) 136 (31%) 16 (14%) 
April 1945 862 (29%) 35 (41%) 144 (33%) 14 (14%) 
Pregnancy Reference§ 3000 84 432 102 
§ Reference: Oxford Nutrition Survey Standards. (Source: Dolsand van Arckeren 1946, p 358) [55]; (% Percentage) 
represents adequacy of intake compared to reference standard. 
3.2. Fasting 
Hormones derived from the placenta including glucagon, cortisol, and human placental lactogen 
create the insulin deficient state in pregnancy and are further increased during periods of stress, such as 
fasting and starvation [61]. During fasting, circulating glucose levels fall, leading to a decrease in insulin 
secretion. At the same time, levels of glucagon and catecholamines resulting in the breakdown of glycogen, 
and gluconeogenesis is increased. As fasting continues for more than several hours, glycogen stores 
become depleted, and the low levels of circulating insulin promote increased fatty acid release from 
adipocytes. Oxidation of fatty acids generates ketones that can be used as fuel by skeletal and cardiac muscle, 
liver, kidney, and adipose tissue, thus sparing glucose for continued utilization by brain and erythrocytes [64]. 
Siega-Riz and colleagues reported that meal patterns of pregnant women and the frequency of food 
intake during pregnancy are relevant to the relationship between maternal nutrition status and preterm 
birth [65]. Risk factors included consuming fewer than three meals and two snacks per day had a 30% 
higher risk for delivering preterm and not eating for >13 h per day had a three-fold greater risk of 
delivering preterm at <34 weeks gestation. Metzger and Felig from two separate studies found that a 16-hour 
fast in a pregnant group resulted in signiﬁcantly lower glucose levels and signiﬁcantly higher free fatty 
acids and -hydroxybutyrate levels in both lean and obese women [66,67]. 
Another condition of religious fasting during the holy month of Ramadan, may pose risks to pregnant 
women. In a sample of 30 fasting pregnant women, Khoshdel and colleagues measured significant changes 
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in follicle stimulating hormone (FSH), estrogen, progesterone and leptin levels (p < 0.05) [68]. Additionally, 
poor weight gain in the pregnant fasted women was observed during the study [68]. In another study, 
Ziaee and colleagues studied a historical cohort of pregnant women seen at Tehran hospitals at one of 
the trimesters in the holy month of Ramadan [69]. The women were divided into non-fasting, 11–20 days 
fasting, and 21–30 days fasting. There was a relative risk of low birth weight incidence in mothers fasting 
during the first trimester compared to the non-fasting mothers [69]. An increased risk of hyperemesis 
gravidarum in Ramadan fasting women during the first month of pregnancy has been found [69]. 
Herrmann and colleagues found that periods without food lasting 13 h during pregnancy compared with 
periods <13 h were associated with elevated maternal corticotrophin-releasing hormone (CRH) concentrations 
after controlling for pre-pregnancy BMI energy intake, income, race, smoking, and maternal age [70]. This 
was the ﬁrst time a plausible mechanism, placental CRH, for the relationship between fasting and a 
greater risk of preterm birth was identiﬁed. Some studies suggest that severe maternal acidosis has an 
adverse maternal and fetal impact including fetal neurological impairment and fetal loss. Similar metabolic 
changes are seen with poor dietary intake or prolonged fasting and resulting acidosis is referred to as 
“starvation ketoacidosis” [64]. 
3.3. Hyperemesis Gravidarum 
The Norwegian Mother and Child Cohort Study comprising of 108,000 births was the setting used to 
explore relationships between hyperemesis gravidarum (HG) and adverse pregnancy outcomes [71]. 
Characteristics of the pregnant women in the cohort who had HG (1.1%) included younger age, less 
education, and were mainly non-smokers before pregnancy. They had lower or higher pre-pregnancy 
BMI compared to those without HG. Additionally, a majority of the women with HG gained less weight 
during pregnancy than those without HG. Women with HG gained on average 12.7 kg during pregnancy, 
compared to 14.9 kg for women without HG [72]. Other complications reported via case studies are 
maternal metabolic alkalosis and neonatal metabolic acidosis [73,74]. In a sample of 33,467 primiparous 
women from the Norwegian Mother and Child Cohort Study (1999−2008), 353 (1.1%) women had 
hyperemesis. Among non-smokers, both underweight and obese women were more likely to develop 
hyperemesis than normal-weighted women: odds ratio (OR), 2.36; 95% confidence interval (95% CI), 
1.43−3.88 and OR, 1.48; 95% CI, 1.00−2.20, respectively [75]. When comparing the results of this cohort to 
other studies, HG was not found to be associated with an increased risk of preterm birth, low birth weight 
and small for gestational age [76,77]. Conflicting results may have been due to the use of different HG 
diagnostic criteria since a universally accepted definition is lacking. Some definitions included dehydration, 
electrolyte disturbances, ketonuria and more than 5% weight loss compared to pre-pregnancy weight 
whereas the Norwegian cohort defined HG as long-lasting nausea and vomiting in pregnancy starting 
before the 25th gestational week, which required hospitalization [72]. Hyperemesis gravidarum can be 
extremely debilitating for women and, if inadequately managed, can cause significant morbidities, 
including malnutrition and electrolyte imbalances, thrombosis, Wernicke’s encephalopathy, depressive 
illness, and poor pregnancy outcomes, such as prematurity and small-for-gestational-age fetuses. [78–81] 
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3.4. Eating Disorders in Pregnancy 
Even less is known about metabolic disturbances in normal weight and obese women during pregnancy 
who either have an active eating disorder (ED) or have a history of one—anorexia nervosa (AN), bulimia 
nervosa (BN), binge-eating disorder (BED) and eating disorders not otherwise speciﬁed (EDNOS) [82,83]. 
Poor nutrition to the fetus is known to negatively impact brain development and increase the risk of 
neuropsychiatric diseases [83,84]. Glucose homeostasis is likely disrupted in pregnant women with ED and 
both symptomatic and asymptomatic hypoglycemia can occur. Women with ED may have lowered blood 
glucose and insulin and may show reactive hypoglycemia after an oral glucose tolerance test [85]. Binging 
on foods with a high glycemic index can lead to a rapid increase in blood glucose level. When this is 
followed by vomiting, disturbance of the complex interaction between gut hormones and digestion occurs, 
resulting in rapid drops in blood glucose and leading to rapid fluctuations in blood glucose [85,86]. 
4. Weight Loss Diets for Obese Pregnant Women and Gestational Diabetes 
There are a few energy/protein restricted studies in pregnant women with overweight/obesity or high 
gestational weight gain [86]. Three trials, involving 384 women, were included. Both Campbell trials 
reported that energy/protein restriction was associated with a signiﬁcant reduction in weekly maternal 
weight gain, although the magnitude of the reduction was much larger in the 1975 trial of Aberdeen 
adults (random effects weighted mean difference (WMD) −254.81 (95% CI –436.56 to −73.06) g/week) 
(Table 4) [87,88]. The 1983 Campbell study found different effects of the mother’s carbohydrate intake 
on blood pressure (BP), depending on the level of animal protein in the diet, with low-carbohydrate, 
high-protein intakes related to reduced placental size and increased BP later in life [88]. Energy/protein 
restriction had no effect on either (proteinuric) pre-eclampsia or pregnancy-induced hypertension (with 
or without proteinuria), although the small number of trials and participants provides inadequate statistical 
power to exclude a small effect. The two trials that reported on birth weight (Badrawi 1993; Campbell 1983) 
yielded highly (and statistically signiﬁcantly) heterogeneous results, with the Campbell 1983 study 
reporting basically no effect of the intervention (WMD 6.00, 95% CI −121.55 to +133.55, g) but the 
1993 Badrawi study found a large signiﬁcant adverse effect (WMD −450.00 g (95% CI −624.72 to 
−275.28) [88,89]. These large differences in results could reﬂect either differences in study samples 
(Scotland vs. Egypt) or differences in the degree of energy/protein restriction achieved. Only the 1983 
Campbell study reported results bearing on gestational duration; the results appear to exclude an important 
adverse effect of dietary restriction (WMD in mean gestational age = +0.25 (−0.17 to +0.67) week) [89]. 
Other outcomes, including fetal/infant mortality and other measures of maternal morbidity (e.g., cesarean 
section) or postpartum weight retention, were not reported [90–94]. The fetal effects from hyperketonemia 
are a major concern by inducing intentional maternal weight loss during pregnancy in obese women. The 
presence of ketosis implies two things: (1) that lipid energy metabolism has been activated and (2) that the 
entire pathway of lipolysis is intact. Ketosis is normal during fasting, and is particularly important for 
the brain, which has no other substantial non-glucose-derived energy source. During the neonatal period, 
infancy, and pregnancy, times at which lipid energy metabolism is particularly active, ketosis develops 
readily [91]. Magee and colleagues conducted a RCT in a metabolic unit to understand the metabolic 
effects of a 1200-calorie diet on obese pregnant women with gestational diabetes [92]. Maternal glycemic 
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status improved in the calorie-restricted group however there were significant increases in ketonemia and 
ketonuria as well. Available research to date does still not explain how hyperketonemia affects fetal 
metabolism, development, and overall safety. 
Table 4. Studies using hypocaloric antenatal diets for obese pregnancy and gestational diabetes. 
Author Sample Dietary Treatment Outcome(s) 
Obese Pregnancy 
Badrawi 1993 [89] 
100 obese multiparous 
Egyptian women age  
25–35 years. 
Treatment: balanced low-energy 
(1500–2000 kcal/day) diet. 
Control: normal diet according to 
WHO energy recommendations 
(2300–3000 kcal/day). 
Gestational weight gain, 
Birth weight, and PIH 
Campbell 1975 [87] 
153 primiparous Scottish 
women with high 
gestational weight gain 
(>1.25 lb. or 570 g per 
week) between  
20 and 30 weeks. 
Intervention: low-energy (1200 
kcal/day), low-carbohydrate diet 
beginning at 30 weeks.  
Control: no intervention. 
Gestational weight gain, 
PIH, and pre-eclampsia 
Campbell 1983 [88] 
182 obese (>75th centile 
weight-for-height) 
Scottish primiparous 
women with normal 
IVGTT 
Intervention: low-energy (1250 
kcal/day) diet. Control:  
no intervention. 
Gestational weight gain, 
birth weight, birth length at 
28 weeks gestational age, 
preterm birth, pre-eclampsia. 
Gestational Diabetes (GDM) 
Knopp 1991 [90] 12 overweight GDM 
1200 kcal (50% restriction) vs. 
2400 kcal 150 g (50%) vs. 300 g 
CHO/d (50%) 
1200 kcal improved 
(randomized) glucose; 
elevated ketones 
Knopp 1991 [91] 
6 overweight GDM 
(randomized) 
1600–1800 (30%–33% 
restriction) vs. 2500 kcal plus 
prophylactic insulin; 200 g (50%) 
vs. 300 g CHO/d (50%) 
1600–1800 kcal restriction 
improved glucose and trig 
with no marked ketonuria 
Algert 1985 [94] 22 obese (non-randomized) 
1700–1800 kcal; 212–225 g 
CHO/d (50%–60%) 
Lower weight gain,  
higher; mean birth weight, 
no ketonuria 
Magee 1990 [92] 12 obese (randomized) 
1200 kcal (50% restriction) vs. 
2400 kcal (usual intake); 150 g 
(50%) vs. 300 g CHO/d) (50%) 
1.200 kcal lowered mean 
glucose, no change in 
fasting plasma glucose, 
Increased ketonemia 
Rae 2000 [93] 
66 intervention vs. control 
with insulin (randomized) 
1590–1776 kcal (30% restriction) 
vs. 2010–2220 kcal; 210–244 g 
(51%) vs. 240–274 g CHO/d (46%) 
No difference in frequency 
of insulin use; lower kcal 
had lower dose; no increase 
in ketones 
Total of 5 studies: N = 553 subjects. 
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5. Beyond Necessary Research 
Ideally, weight loss should occur before pregnancy, however in 2006, 49% of pregnancies in the 
United States were unintended—a slight increase from 48% in 2001 [95]. Realistically, significant 
weight loss is unlikely to happen before pregnancy with the exception of bariatric surgery. Larger RCTs 
are needed with specific attention to safety. Recruitment may be difficult as seen in other trials due to 
the stigma associated with obesity and the sensitivity (or lack of) from health care professionals who 
treat obese patients [36]. Delicate training of study staff will improve compassion especially with study 
interactions and the use of large anthropometric equipment used to weigh and measure obese subjects. 
Women with polycystic ovary syndrome (PCOS) who become pregnant and classified as obese 
include a specific population who would benefit from weight loss research to prevent GDM and other 
maternal and infant complications. Weight loss for women with PCOS helps reduce the male hormone 
levels, obesity, and some women will begin to ovulate naturally. The effects of weight loss on hormone 
levels (estrogen, FSH, LH, testosterone and 17-ketosteroids) are unknown for obese pregnant women 
with PCOS [96]. Other unknown metabolic consequences of intentional weight loss in obese pregnant 
women in need of further investigation include hyperinsulinemia effects on protein synthesis, optimal 
energy restriction, and rate of weight loss exclusive of maternal and fetal adverse outcomes, amino acid 
decrease in amniotic fluid, safest meal spacing, ideal monitoring parameters, and increased ketones to 
name a few [97]. 
More investigation about defining a minimum adequate diet for pregnant women is critical for safe 
weight loss for maternal and fetal health. Long-term effects of weight loss diets during pregnancy 
without starvation will stipulate future cohorts to monitor the development of degenerative and chronic 
disease [98]. 
6. Conclusions 
This paper highlights the possibility that safe weight loss during pregnancy for obese women is an 
opportunity for further investigation. It appears from available weight loss studies that 1600–1700 kcal 
per day does not produce ketonuria as long as 50% of the calories are provided with carbohydrate, and 
adequate protein, fat and micronutrients for pregnancy are supplied. Frequent monitoring during intentional 
pregnancy weight loss should include indirect calorimetry, serum ketones and fasting blood glucose and 
at a minimum. 
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